We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Gives Thumbs-Up to Genentech’s Polivy for B Cell Lymphoma
Advisory Committee Gives Thumbs-Up to Genentech’s Polivy for B Cell Lymphoma
The FDA’s Oncologic Drugs Advisory Committee cleared the way for a new combination treatment aimed at providing curative therapy for patients with previously untreated large B cell lymphoma.